ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

LDG Longs Drug Stores Corp

0.00
0.00 (0.00%)
Share Name Share Symbol Market Type
Longs Drug Stores Corp NYSE:LDG NYSE Ordinary Share
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.00 -

- Statement of Ownership (SC 13G)

13/02/2009 8:07pm

Edgar (US Regulatory)


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

SCHEDULE 13G
Under the Securities and Exchange Act of 1934
(Amendment No. ______________)

Longs Drug Stores Corp.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

543162101

(CUSIP Number)

December 31, 2008

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to
which this Schedule is filed:

[X] Rule 13d-1 (b)
[ ] Rule 13d-1 (c)
[ ] Rule 13d-1 (d)

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes.)

CUSIP NO. 543162101 13G


1 Name of Reporting Person / IRS Identification Number:
 Advisory Research, Inc. / 36-2831881

------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (a) [ ]
 (See Instructions) (b) [ ]

------------------------------------------------------------------
3 SEC Use Only

------------------------------------------------------------------
4 Citizenship or Place of Organization
 Delaware

------------------------------------------------------------------



 Number of
 5 Sole Voting Power
 Shares 0 Shares
 -----------------------------------------------
 Beneficially
 6 Shared Voting Power
 Owned By 0 Shares
 -----------------------------------------------
 Each
 7 Sole Dispositive Power
 Reporting 0 Shares
 -----------------------------------------------
 Person
 8 Shared Dispositive Power
 With 0 Shares
------------------------------------------------------------------
9 Aggregate Amount Beneficially Owned by Each Reporting Person
 0 Shares

------------------------------------------------------------------
10 Check if the Aggregate Amount in Row (9) Excludes Certain
 Shares [ ] (See Instructions)

------------------------------------------------------------------
11 Percent of Class Represented by Amount in Row (9)
 0.0%

------------------------------------------------------------------
12 Type of Reporting Person
 IA

------------------------------------------------------------------



Item 1 (a) Name of Issuer: Longs Drug Stores Corp.
Item 1 (b) Name of Issuer's Principal Executive Offices:
 141 North Civic Drive
 Walnut Creek, CA 94596

Item 2 (a) Person Filing: Advisory Research, Inc.
Item 2 (b) Address: 180 North Stetson St., Suite 5500
 Chicago, IL 60601

Item 2 (c) Citizenship: Advisory Research, Inc. is a
 Delaware Corporation

Item 2 (d) Title of Class of Securities: Common Stock
Item 2 (e) CUSIP Number: 543162101

Item 3 If this statement is filed pursuant to Rules
 13d-1(b) or 13d-2(b), check whether the person
 filing is a:

 (a) [ ] Broker or Dealer registered under Section
 15 of the Act

 (b) [ ] Bank as defined in Section 3(a)(6) of the
 Act

 (c) [ ] Insurance Company as defined in Section
 3(a)(19) of the Act

 (d) [ ] Investment Company registered under
 Section 8 of the Investment Company Act

 (e) [X] Investment Advisor in accordance with
 section 240.13d-1(b)(1)(ii)(E)

 (f) [ ] Employee Benefit Plan or Endowment Fund
 in accordance with section 240.13d-1(b)
 (1)(ii)(F)

 (g) [ ] Parent Holding Company or Control Person
 in accordance with section 13d-1(b)
 (1)(ii)(G)

 (h) [ ] A savings association as defined in
 section 3(b) of the Federal Deposit
 Insurance Act

 (i) [ ] A church plan that is excluded from
 the definition of an investment company
 under section 3(c)(14) of the Investment
 Company Act of 1940

Item 4 Ownership

 (a) Amount Beneficially Owned:
 Advisory Research, Inc. 0 Shares

 (b) Percent of Class 0.0%

 (c) Number of shares as to which reporting person has:
 (i) Sole Voting Power 0 Shares
 (ii) Shared Voting Power 0 Shares
 (iii) Sole Dispositive Power 0 Shares
 (iv) Shared Dispositive Power 0 Shares

Item 5 Ownership of Five Percent or Less of a Class:
 If this statement is being filed to report the fact
 that as of the date hereof the reporting person has
 ceased to be the beneficial owner of more than five
 percent of the class of securities, check the
 following [X]

Item 6 Ownership of More than Five Percent on Behalf of
 Another Person: Not Applicable

Item 7 Identification and Classification of the Subsidiary
 Which Acquired the Security being Reported on by the
 Parent Holding Company: Not Applicable

Item 8 Identification and Classification if Members of
 the Group: Not Applicable

Item 9 Notice of Dissolution of Group: Not Applicable

Item 10 Certification

 By signing below I certify that, to the best of my
 knowledge and belief, the securities referred to
 above were acquired and are held in the ordinary
 course of business and were not acquired and are
 not held for the purpose of or with the effect of
 changing or influencing the control of the issuer
 of such securities and were not acquired and are
 not held in connection with or as a participant
 in any transaction having such purposes or effect.

 SIGNATURE

After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this
statement is true, complete and correct.

 02/13/2009
 ----------------------------------
 Date

 /s/ Brien M. O'Brien
 ----------------------------------
 Signature

 Brien M. O'Brien, Chairman & CEO
 ----------------------------------
 Name/Title

1 Year Longs Drug Stores Chart

1 Year Longs Drug Stores Chart

1 Month Longs Drug Stores Chart

1 Month Longs Drug Stores Chart

Your Recent History

Delayed Upgrade Clock